Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by North Star Asset Management Inc.

Key Points

• North Star Asset Management Inc. has reduced its holdings in Prestige Consumer Healthcare Inc. by 12.1%, now owning 198,191 shares worth approximately $17 million.
• Analysts have upgraded Prestige Consumer Healthcare, with ratings shifting from "hold" to "buy," leading to an average target price of $93.33 for the stock.
• The company's latest earnings report showed a 7.0% year-over-year revenue increase and a quarterly earnings per share of $1.32, exceeding analyst expectations.

North Star Asset Management Inc. lessened its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 12.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 198,191 shares of the company's stock after selling 27,172 shares during the period. North Star Asset Management Inc. owned 0.40% of Prestige Consumer Healthcare worth $17,038,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. GAMMA Investing LLC boosted its position in shares of Prestige Consumer Healthcare by 35.9% in the 1st quarter. GAMMA Investing LLC now owns 1,879 shares of the company's stock worth $162,000 after purchasing an additional 496 shares in the last quarter. KBC Group NV boosted its position in shares of Prestige Consumer Healthcare by 7.4% in the 1st quarter. KBC Group NV now owns 2,199 shares of the company's stock worth $189,000 after purchasing an additional 151 shares in the last quarter. QRG Capital Management Inc. boosted its position in shares of Prestige Consumer Healthcare by 8.6% in the 1st quarter. QRG Capital Management Inc. now owns 5,971 shares of the company's stock worth $513,000 after purchasing an additional 475 shares in the last quarter. Norges Bank acquired a new stake in shares of Prestige Consumer Healthcare in the 4th quarter worth $40,009,000. Finally, BNP Paribas Financial Markets boosted its position in shares of Prestige Consumer Healthcare by 1,073.3% in the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock worth $15,923,000 after purchasing an additional 186,524 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of recent analyst reports. Royal Bank Of Canada raised Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Performance

PBH traded down $0.22 on Friday, reaching $73.73. 423,917 shares of the stock were exchanged, compared to its average volume of 406,596. The company's 50-day moving average price is $80.65 and its 200 day moving average price is $82.27. The firm has a market capitalization of $3.64 billion, a PE ratio of 17.19, a PEG ratio of 2.22 and a beta of 0.43. Prestige Consumer Healthcare Inc. has a fifty-two week low of $64.94 and a fifty-two week high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. The business had revenue of $296.52 million during the quarter, compared to analyst estimates of $289.36 million. Prestige Consumer Healthcare had a return on equity of 12.87% and a net margin of 18.86%. The company's revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the business posted $1.02 EPS. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.